Works by Walcott, Farzana L.

Results: 5
    1
    2

    Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 12, p. 1789, doi. 10.1080/10428194.2024.2373331
    By:
    • Dimopoulos, Meletios A.;
    • Migkou, Magdalini;
    • Bhutani, Manisha;
    • Ailawadhi, Sikander;
    • Kalff, Anna;
    • Walcott, Farzana L.;
    • Pore, Nabendu;
    • Brown, Miranda;
    • Wang, Fujun;
    • Cheng, Lily I.;
    • Kagiampakis, Ioannis;
    • Williams, Marna;
    • Kinneer, Krista;
    • Wu, Yuling;
    • Jiang, Yu;
    • Kubiak, Robert J.;
    • Zonder, Jeffrey A.;
    • Larsen, Jeremy;
    • Sirdesai, Shreerang;
    • Yee, Andrew J.
    Publication type:
    Article
    3
    4
    5

    Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome.

    Published in:
    2017
    By:
    • Ping-yuan Wang;
    • Jie Li;
    • Walcott, Farzana L.;
    • Ju-Gyeong Kang;
    • Starost, Matthew F.;
    • Talagala, Lalith;
    • Jie Zhuang;
    • ji-Hoon Park;
    • Huffstutler, Rebecca D.;
    • Bryla, Christina M.;
    • Mai, Phuong L.;
    • Pollak, Michael;
    • Annunziata, Christina M.;
    • Savage, Sharon A.;
    • Fojo, Antonio Tito;
    • Hwang, Paul M.;
    • Wang, Ping-Yuan;
    • Li, Jie;
    • Kang, Ju-Gyeong;
    • Talagala, S Lalith
    Publication type:
    journal article